NDC 66733-948-23
ERBITUX 2 mg/mL
cetuximab · SOLUTION
Erbitux (cetuximab) is a prescription medication given by intravenous infusion that works by blocking epidermal growth factor receptors, and it is used to treat certain types of cancer including colorectal cancer and head and neck cancer. This drug helps slow or stop the growth of cancer cells that rely on these receptors.
Key Facts
- Brand Name
- ERBITUX
- Generic Name
- cetuximab
- NDC Code (Package)
66733-948-23- NDC Code (Product)
66733-948- Manufacturer
- ImClone LLC
- Strength
- 2 mg/mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125084
- Drug Class
- Epidermal Growth Factor Receptor Antagonist [EPC]
- Marketing Start
- 02/12/2004
Recall History
No Recall HistoryView Full Drug Page
ERBITUX — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.